ICU Medical, Inc.
ICUI · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $536,990 | $548,866 | $604,702 | $629,805 |
| % Growth | -2.2% | -9.2% | -4% | – |
| Cost of Goods Sold | $336,109 | $340,802 | $394,593 | $402,547 |
| Gross Profit | $200,881 | $208,064 | $210,109 | $227,258 |
| % Margin | 37.4% | 37.9% | 34.7% | 36.1% |
| R&D Expenses | $21,251 | $21,867 | $23,291 | $22,355 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $152,773 | $159,392 | $157,233 | $158,849 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $13,138 | $16,218 | $16,697 | $8,363 |
| Operating Expenses | $187,162 | $197,477 | $197,221 | $189,567 |
| Operating Income | $13,719 | $10,587 | $12,888 | $37,691 |
| % Margin | 2.6% | 1.9% | 2.1% | 6% |
| Other Income/Exp. Net | -$17,773 | $25,929 | -$23,794 | -$29,474 |
| Pre-Tax Income | -$4,054 | $36,516 | -$10,906 | $8,217 |
| Tax Expense | -$658 | $1,178 | $4,570 | $32,045 |
| Net Income | -$3,396 | $35,338 | -$15,476 | -$23,828 |
| % Margin | -0.6% | 6.4% | -2.6% | -3.8% |
| EPS | -0.14 | 1.43 | -0.63 | -0.97 |
| % Growth | -109.8% | 327% | 35.1% | – |
| EPS Diluted | -0.14 | 1.43 | -0.63 | -0.97 |
| Weighted Avg Shares Out | 24,686 | 24,645 | 24,539 | 24,492 |
| Weighted Avg Shares Out Dil | 24,686 | 24,708 | 24,539 | 24,492 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $2,516 | $3,232 | $2,731 |
| Interest Expense | $19,808 | $23,065 | $29,019 | $26,188 |
| Depreciation & Amortization | $50,802 | $49,665 | $49,445 | $53,012 |
| EBITDA | $66,556 | $106,409 | $63,802 | $87,417 |
| % Margin | 12.4% | 19.4% | 10.6% | 13.9% |